Advertisement
U.S. Markets closed

WntResearch AB (WNT.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
0.8300-0.0700 (-7.78%)
At close: 04:31PM CEST

WntResearch AB

Stora Södergatan 15
Lund 222 23
Sweden

https://www.wntresearch.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 2

Key Executives

NameTitlePayExercisedYear Born
Dr. Thomas Andersson Ph.D.Founder, Chief Scientific Officer, Director & Scientific Advisor572kN/A1956
Dr. Per Goran Oskar Norlen M.D., Ph.D.Chief Executive OfficerN/AN/A1970
Mr. Anders TidforsChief Financial OfficerN/AN/A1964
Dr. Kicki JohanssonChief Operating OfficerN/AN/A1958
Mr. Dennis B. Henriksen M.Sc., Ph.D.Chief Technical Officer418.81kN/A1962
Mr. Klaus ChristensenChief Commercial OfficerN/AN/A1968
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

WntResearch AB, a biotech company, develops therapies to prevent the metastatic process. The company develops Foxy-5, a peptide, which is in Phase II clinical trials that reduced the risk of metastasis in patients with colon cancer. It is also developing Box-5, a WNT5A antagonist for the treatment of malignant melanoma, and pancreatic and gastric cancer. The company was incorporated in 2007 and is based in Lund, Sweden.

Corporate Governance

WntResearch AB’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.